Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Mabuterol hydrochloride

Related Products

Hot Products

Name

Mabuterol hydrochloride

EINECS 1312995-182-4
CAS No. 56341-08-3 Density 1.278 g/cm3
PSA 58.28000 LogP 4.33460
Solubility N/A Melting Point 85-87oC
Formula C13H18ClF3N2O Boiling Point 375.9 °C at 760 mmHg
Molecular Weight 310.747 Flash Point 181.1 °C
Transport Information N/A Appearance N/A
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 56341-08-3 (MABUTEROL) Hazard Symbols N/A
Synonyms

4-Amino-alpha-((tert-butylamino)methyl)-3-chloro-5-(trifluoromethyl)benzyl alcohol;Ambuterol;Mabuterolum;4-Amino-3-chloro-alpha-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)benzenemethanol;Broncholin;

Article Data 3

Mabuterol hydrochloride Chemical Properties

Product Name: KF-868 (CAS NO.54240-36-7)


Molecular Formula: C13H18ClF3N2O.HCl
Molecular Weight: 347.2g/mol
Mol File: 54240-36-7.mol
Appearance: A solid
Boiling point: 375.9°Cat760mmHg
Flash Point: 181.1 °C
Enthalpy of Vaporization: 65.77 kJ/mol
Vapour Pressure: 2.57E-06 mmHg at 25°C
H-Bond Donor: 4
H-Bond Acceptor: 6

Mabuterol hydrochloride Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 27500ug/kg (27.5mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
dog LD50 oral 229mg/kg (229mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
human TDLo oral 1143ng/kg (0.001143mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: HEADACHE
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1697, 1984.
human TDLo oral 60ug/kg/6W (0.06mg/kg) BEHAVIORAL: TREMOR

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1699, 1984.
mouse LD50 intraperitoneal 60mg/kg (60mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
mouse LD50 intravenous 36500ug/kg (36.5mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 652, 1984.
mouse LD50 oral 200mg/kg (200mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
mouse LD50 subcutaneous 113mg/kg (113mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rabbit LD50 intravenous 18300ug/kg (18.3mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rabbit LD50 oral 243mg/kg (243mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 intraperitoneal 76300ug/kg (76.3mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 intravenous 26400ug/kg (26.4mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 oral 306mg/kg (306mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 subcutaneous 117mg/kg (117mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.

Mabuterol hydrochloride Safety Profile

Poison by intravenous route. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of F, NOx, and HCl.

Mabuterol hydrochloride Specification

 KF-868 ,its CAS NO. is 54240-36-7,the synonyms is Mabuterolhcl ; Benzenemethanol, 4-amino-3-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)-, monohydrochloride (9ci) ; Broncholin ; Dl-mabuterol hydrochloride ; KF868 (pharmaceutical) .

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56341-08-3